Physician profile
Patrick A Raney
NPI 1821165861
$1,822.19
in general payments reported to CMS, 2019-2025
19 companies · $47.81 in 2025
The $47.81 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,375 · 2020: $258 · 2021: $24.23 · 2022: $117 · 2025: $47.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $397.47 | 2019-2022 | |
| Lilly USA, LLC | $224.10 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $177.81 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $157.75 | 2019-2020 | |
| Amgen INC. | $143.14 | 2019-2020 | |
| Glaxosmithkline, LLC. | $142.66 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.96 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $68.09 | 2019 | |
| Janssen Pharmaceuticals, INC | $64.53 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.18 | 2019 | |
| Ascensia Diabetes Care US INC. | $47.81 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $46.33 | 2019-2020 | |
| Allergan, INC. | $41.57 | 2020 | |
| Ironwood Pharmaceuticals, INC | $26.78 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.00 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $24.23 | 2021 | |
| Tris Pharma INC | $17.29 | 2019 | |
| Amarin Pharma, INC. | $14.52 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Raney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.